Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease Vaccines
Studies in the area of Alzheimer disease vaccines reported from University of Konstanz
May 7th, 2008
A report, 'Design, structural, and immuno-analytical properties of antigenic bioconjugates comprising a beta-amyloid-plaque specific epitope,' is newly published data in Biopolymers. "Immunotherapeutic approaches are investigated for treatment of neurodegenerative diseases of the Alzheimer's dementia (AD) type. The identification of a beta-amyloid-plaque specific epitope, Abeta(4-10) (4FRHDSGY10), recognized by therapeutically active antibodies from transgenic AD mice could provide the basis for the development of AD vaccines," investigators in Konstanz, Germany report. "Here we report on the synthesis, structural and immuno-analytical characterization of...
Source: Vaccine Weekly (2008-05-07)
|
